glp-1 news today september 2025 RA prescription trends: January 2018 – 2025 dominates for GLP-1 trial

GLP-1-related hair loss is called telogen effluvium, which causes sudden, diffuse shedding usually temporary

Limitations The major limitations of the studies that are included in this systematic review are the enrollment of healthy subjects and insufficient data in conditions that might affect pharmacokinetics (e.g., kidney dysfunction)

Lightweight and portable, they provide a refreshing, soothing feel that complements your daily routine

But researchers arent done sharpening the edge

Unlike FDA-approved medications (e.g., Wegovy, Ozempic, Zepbound), compounded alternatives lack agency review for safety, quality, and efficacy